The level of interleukin-8 (IL-8) is also found to be upregulated in a range of cancers and contribute to EMT and resistance to cisplatin in OSCC cells, while the blocking of it can reverse these effects (Joshi et al., 2023). This evidence concerns the gene CXCL8 and cancer.